APA (7th ed.) Citation

Wu, Z., Zheng, Y., Sheng, J., Han, Y., Yang, Y., Pan, H., & Yao, J. (2022). CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer. Frontiers in immunology, 13, 816005. https://doi.org/10.3389/fimmu.2022.816005

Chicago Style (17th ed.) Citation

Wu, Zhiheng, Yu Zheng, Jin Sheng, Yicheng Han, Yanyan Yang, Hongming Pan, and Junlin Yao. "CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer." Frontiers in Immunology 13 (2022): 816005. https://doi.org/10.3389/fimmu.2022.816005.

MLA (9th ed.) Citation

Wu, Zhiheng, et al. "CD3+CD4-CD8- (Double-Negative) T Cells in Inflammation, Immune Disorders and Cancer." Frontiers in Immunology, vol. 13, 2022, p. 816005, https://doi.org/10.3389/fimmu.2022.816005.